MBM Commercial recently advised Current Health, a pioneering firm in wearable healthcare devices, on its Series A funding. The firm is planning expansion and will be opening a US head office in New York having secured three Food and Drug Adminstration clearances for its platform.
The Series A funding was led by MMC Ventures and participating in the round were Current Health’s first corporate investor Legal & General. Further investment was made by Par Equity and Scottish Investment Bank.
Laura Peachey - Director, Tracey Ginn - Partner, and Rachel Miele -Trainee Solicitor within the Corporate Group, guided Current Health through each stage of the round, from the due diligence process to a successful closing.
“We have worked with the team at Current Health for a number of years”, said Laura, “so it’s very satisfying to see the company’s continued success and we were delighted to assist them in this round of funding to help them in their next phase of expansion.”
Chris McCann, Founder and CEO of Current Health noted: “The MBM team guided us through the fundraising process with ease. They were in our corner throughout and provided sound commercial advice and practical deal management, helping us to navigate any challenges along the way and to bring the process to a successful conclusion.”
MBM Commercial is an award-winning commercial law firm that helps entrepreneurial businesses to start-up, scale up and go global. The firm advises on all aspects of corporate law with particular expertise in both acting for a range of investor companies and companies receiving investment. For further information please contact us.